Investigations of AGEs’ inhibitory and nephroprotective potential of ursolic acid towards reduction of diabetic complications

Antidiabetic profiling, cytotoxicity and acute toxicity evaluation of aerial parts of Phragmites karka (Retz.)

(2021) Kishor Mazumder et al.   JOURNAL OF ETHNOPHARMACOLOGY

Terpenoids enriched ethanol extracts of aerial roots of Ceriops decandra (Griff.) and Ceriops tagal (Perr.) promote diuresis in mice

(2021) Biswajit Biswas et al.   Heliyon

3′-O-β-d-glucopyranosyl-α,4,2′,4′,6′-pentahydroxy-dihydrochalcone, from Bark of Eysenhardtia polystachya Prevents Diabetic Nephropathy via Inhibiting Protein Glycation in STZ-Nicotinamide Induced Diabetic Mice

(2019) Rosa Pérez Gutierrez et al.   MOLECULES

Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway

(2019) Tiankui Ma et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach

(2018) Nausheen Nazir et al.   BMC Complementary and Alternative Medicine

Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective

(2017) Salvatore Bongarzone et al.   JOURNAL OF MEDICINAL CHEMISTRY

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

(2017) Antoine Daina et al.   Scientific Reports

The mechanism of action of ursolic acid as insulin secretagogue and insulinomimetic is mediated by cross-talk between calcium and kinases to regulate glucose balance

(2015) Allisson Jhonatan Gomes Castro et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

PubChem Substance and Compound databases

(2015) Sunghwan Kim et al.   NUCLEIC ACIDS RESEARCH

Advanced Glycation End Products and Diabetic Complications

(2014) Varun Parkash Singh et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy

(2013) Yusuke Kaida et al.   DIABETES

Evaluation of the in vitro inhibitory effects of buckwheat enhanced wheat bread extracts on the formation of advanced glycation end-products (AGEs)

(2013) Dorota Szawara-Nowak et al.   LWT-FOOD SCIENCE AND TECHNOLOGY

Inhibitory Effect of Metformin and Pyridoxamine in the Formation of Early, Intermediate and Advanced Glycation End-Products

(2013) Saheem Ahmad et al.   PLoS One

Metformin Inhibits Advanced Glycation End Products (AGEs)-induced Renal Tubular Cell Injury by Suppressing Reactive Oxygen Species Generation via Reducing Receptor for AGEs (RAGE) Expression

(2012) Y. Ishibashi et al.   HORMONE AND METABOLIC RESEARCH

Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis

(2011) Sarah L. Ullevig et al.   ATHEROSCLEROSIS

Ursolic acid derivatives from Bangladeshi medicinal plant, Saurauja roxburghii: Isolation and cytotoxic activity against A431 and C6 glioma cell lines

(2011) Kishor Mazumder et al.   Phytochemistry Letters

Inhibition of advanced glycation endproduct formation by foodstuffs

(2011) Chi-Hao Wu et al.   Food & Function

Ursolic Acid Attenuates D-Galactose-Induced Inflammatory Response in Mouse Prefrontal Cortex through Inhibiting AGEs/RAGE/NF- B Pathway Activation

(2010) J. Lu et al.   CEREBRAL CORTEX

Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes

(2010) Sho-ichi Yamagishi   EXPERIMENTAL GERONTOLOGY

A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu

(2010) Stefan Grimme et al.   JOURNAL OF CHEMICAL PHYSICS

Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice

(2009) Zhi-hong Wang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Ursolic acid enhances the cellular immune system and pancreatic β-cell function in streptozotocin-induced diabetic mice fed a high-fat diet

(2008) Sun-Mi Jang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications

(2007) Giuseppina Basta   ATHEROSCLEROSIS

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes

(2007) Kazuo Nakamura et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS